Design–functionality relationships for adhesion/growth-regulatory galectins

Glycan-lectin recognition is assumed to elicit its broad range of (patho)physiological functions via a combination of specific contact formation with generation of complexes of distinct signal-triggering topology on biomembranes. Faced with the challenge to understand why evolution has led to three...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 116; no. 8; pp. 2837 - 2842
Main Authors Ludwig, Anna-Kristin, Michalak, Malwina, Xiao, Qi, Gilles, Ulrich, Medrano, Francisco J., Ma, Hanyue, FitzGerald, Forrest G., Hasley, William D., Melendez-Davila, Adriel, Liu, Matthew, Rahimi, Khosrow, Kostina, Nina Yu, Rodriguez-Emmenegger, Cesar, Möller, Martin, Lindner, Ingo, Kaltner, Herbert, Cudic, Mare, Reusch, Dietmar, Kopitz, Jürgen, Romero, Antonio, Oscarson, Stefan, Klein, Michael L., Gabius, Hans-Joachim, Percec, Virgil
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 19.02.2019
Subjects
Online AccessGet full text
ISSN0027-8424
1091-6490
1091-6490
DOI10.1073/pnas.1813515116

Cover

More Information
Summary:Glycan-lectin recognition is assumed to elicit its broad range of (patho)physiological functions via a combination of specific contact formation with generation of complexes of distinct signal-triggering topology on biomembranes. Faced with the challenge to understand why evolution has led to three particular modes of modular architecture for adhesion/growth-regulatory galectins in vertebrates, here we introduce protein engineering to enable design switches. The impact of changes is measured in assays on cell growth and on bridging fully synthetic nanovesicles (glycodendrimersomes) with a chemically programmable surface. Using the example of homodimeric galectin-1 and monomeric galectin-3, the mutual design conversion caused qualitative differences, i.e., from bridging effector to antagonist/from antagonist to growth inhibitor and vice versa. In addition to attaining proof-of-principle evidence for the hypothesis that chimera-type galectin-3 design makes functional antagonism possible, we underscore the value of versatile surface programming with a derivative of the pan-galectin ligand lactose. Aggregation assays with N,N′-diacetyllactosamine establishing a parasite-like surface signature revealed marked selectivity among the family of galectins and bridging potency of homodimers. These findings provide fundamental insights into design-functionality relationships of galectins. Moreover, our strategy generates the tools to identify biofunctional lattice formation on biomembranes and galectin-reagents with therapeutic potential.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
1A.-K.L., M. Michalak, Q.X., U.G., F.J.M., H.M., and F.G.F. contributed equally to this work.
Reviewers: E.F.-M., Universidade de Santiago de Compostela; A.R., Wayne State University; and S.S., Laval University.
Author contributions: J.K., M.L.K., H.-J.G., and V.P. designed research; A.-K.L., M. Michalak, Q.X., U.G., F.J.M., H.M., F.G.F., W.D.H., A.M.-D., M.L., K.R., N.Y.K., C.R.-E., M. Möller, and J.K. performed research; A.-K.L. and H.M. contributed new reagents/analytic tools; A.-K.L., M. Michalak, Q.X., U.G., F.J.M., M. Möller, I.L., H.K., M.C., D.R., J.K., A.R., S.O., M.L.K., H.-J.G., and V.P. analyzed data; and M.L.K., H.-J.G., and V.P. wrote the paper.
Contributed by Michael L. Klein, December 19, 2018 (sent for review August 6, 2018; reviewed by Eduardo Fernandez-Megia, Avraham Raz, and Sachiko Sato)
ISSN:0027-8424
1091-6490
1091-6490
DOI:10.1073/pnas.1813515116